Showing 2 Result(s)
上海后花园论坛

Dr. Reddy’s launches direct-to-consumer e-commerce website ‘Celevida Wellness’ for diabetes

Dr. Reddy’s Laboratories Ltd. on Wednesday announced the launch of its first direct-to-consumer (D2C) e-commerce website ‘Celevida Wellness’ for diabetes patients by its wholly-owned subsidiary, Svaas Wellness Limited. ‘Celevida Wellness’ aims to become a one-stop solution for personalised diabetic care for Type 2 diabetic and pre-diabetic individuals, the company said in a statement. Since its …

上海后花园论坛

DCGI approves MSD India’s drug to treat triple-negative breast cancer and renal cell carcinoma

MSD (known as Merck in U.S. and Canada) recently announced that the Drug Controller General of India (DCGI) has approved KEYTRUDA (pembrolizumab), MSD’s anti-PD-1 therapy, for the treatment of triple-negative breast cancer and renal cell carcinoma in adults. KEYTRUDA has been approved for high-risk early-stage and metastatic triple-negative breast cancer for select patients who are …

浙ICP备15045783号-4